NTUS News and Press, Natus Medical Incorporated From 05/06/21

PLEASANTON, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for...

PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders ...

PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders...

Natus Medical Incorporated (NTUS) Q4 2020 Results Earnings Conference Call February 25, 2021, 4:30 PM ET Company Participants Jonathan Kennedy - President and CEO Drew Davies - Executive Vice President and CFO Conference Call Participants Jayson Bedford - Raymond James Presentation Operator G...

Image source: The Motley Fool. Natus Medical Incorporated (NASDAQ: NTUS) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Natus Medical Incorporated (NTUS) Q4 2020 Earnings Call Transcri...

Natus Medical (NTUS): Q4 Non-GAAP EPS of $0.39 beats by $0.15; GAAP EPS of $0.15 beats by $0.19.Revenue of $118.7M (-9.9% Y/Y) beats by $8.7M.Press Release For further details see: Natus Medical EPS beats by $0.15, beats on revenue

PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...

Natus Medical (NTUS) updated Q4 revenue guidance wherein it expects revenue to be between $118 and $119M vs. earlier revenue expectation to be between $104 and $114M.Non-GAAP EPS guidance stands at $0.19 and $0.31; non-GAAP earnings excludes charges of ~$4.1M for amortization expense which th...

39th Annual JP Morgan Healthcare Conference 23rd Annual Needham Growth Conference PLEASANTON, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical devi...

PLEASANTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders ...